Skip to Content
Merck
  • Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia.

Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia.

Experimental and therapeutic medicine (2014-11-06)
Mei Ding, Daoyuan Si, Wenqi Zhang, Zhaohui Feng, Min He, Ping Yang
PMID25371725
ABSTRACT

Xuezhikang (XZK), an extract of red yeast rice, has been widely used for the management of hyperlipidemia and coronary heart disease (CHD); however, the effects of XZK treatment on kidney injury have not yet been fully identified. The aim of the current study was to evaluate the effects of XZK on the kidneys and investigate the related mechanisms in a rat model of hyperlipidemia. Thus, the effect on inflammatory transcription factors and kidney damage was investigated with

MATERIALS
Product Number
Brand
Product Description
860336
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥99%
C8667
Sigma-Aldrich
Cholesterol, Sigma Grade, ≥99%
C9756
Sigma-Aldrich
Cholecalciferol, ≥98% (HPLC)
T2885
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥98% (TLC)
1131009
USP
Cholecalciferol, United States Pharmacopeia (USP) Reference Standard
PHR1533
Supelco
Cholesterol, Pharmaceutical Secondary Standard; Certified Reference Material
C2150000
Cholecalciferol for system suitability, European Pharmacopoeia (EP) Reference Standard
V-025
Supelco
Vitamin D3 solution, 1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
PHR1237
Supelco
Cholecalciferol (Vitamin D3), Pharmaceutical Secondary Standard; Certified Reference Material